The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Baicalin mitigates cognitive impairment and protects neurons from microglia‐mediated neuroinflammation via suppressing NLRP 3 inflammasomes and TLR 4/NF‐κB signaling pathway
Open accessAbstract
Summary: Aims: Baicalin (BAI), a flavonoid compound isolated from the root of Scutellaria baicalensis Georgi, has been established to have potent anti‐inflammation and neuroprotective properties; however, its effects during Alzheimer's disease (AD) treatment have not been well studied. This study aimed to investigate the effects of BAI pretreatment on cognitive impairment and neuronal protection against microglia‐induced neuroinflammation and to explore the mechanisms underlying its anti‐inflammation effects. Methods: To determine whether BAI plays a positive role in ameliorating the memory and cognition deficits in APP (amyloid beta precursor protein)/PS1 (presenilin‐1) mice, behavioral experiments were conducted. We assessed the effects of BAI on microglial activation, the production of proinflammatory cytokines, and neuroinflammation‐mediated neuron apoptosis in vivo and in vitro using Western blot, RT‐PCR, ELISA, immunohistochemistry, and immunofluorescence. Finally, to elucidate the anti‐inflammation mechanisms underlying the effects of BAI, the protein expression of NLRP 3 inflammasomes and the expression of proteins involved in the TLR 4/NF‐κB signaling pathway were measured using Western blot and immunofluorescence. Results: The results indicated that BAI treatment attenuated spatial memory dysfunction in APP/PS 1 mice, as assessed by the passive avoidance test and the Morris water maze test. Additionally, BAI administration effectively decreased the number of activated microglia and proinflammatory cytokines, as well as neuroinflammation‐mediated neuron apoptosis, in APP/PS 1 mice and LPS (lipopolysaccharides)/Aβ‐stimulated BV 2 microglial cells. Lastly, the molecular mechanistic study revealed that BAI inhibited microglia‐induced neuroinflammation via suppression of the activation of NLRP 3 inflammasomes and the TLR 4/NF‐κB signaling pathway. Conclusion: Overall, the results of the present study indicated that BAI is a promising neuroprotective compound for use in the prevention and treatment of microglia‐mediated neuroinflammation during AD progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Signaling to NF-κB by Toll-like receptors
Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,388
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
Kuida, K., Zheng, T. S., Na, S., Kuan, C.-Y., Yang, D., Karasuyama, H., Rakic, P., & Flavell, R. A. (1996) · Nature · doi:10.1038/384368a0 · Cited by 1,882
Microglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Mridha, A. R., Wree, A., Robertson, A. A. B., Yeh, M. M., Johnson, C. D., Van Rooyen, D. M., Haczeyni, F., Teoh, N. C.-H., Savard, C., Ioannou, G. N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.022 · Cited by 1,110
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986
The myeloid cells of the central nervous system parenchyma
Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804
Guidelines for Prevention of NSAID-Related Ulcer Complications
and the Practice Parameters Committee of the American College of Gastroenterology, Lanza, F. L., Chan, F. K. L., & Quigley, E. M. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.115 · Cited by 790
Zhang, G., & Ghosh, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11837 · Cited by 777
Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
Juliana, C., Fernandes-Alnemri, T., Kang, S., Farias, A., Qin, F., & Alnemri, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407130 · Cited by 773
Microglia: biology and pathology
Graeber, M. B., & Streit, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0622-0 · Cited by 725
Immune activation in brain aging and neurodegeneration: too much or too little?
Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
McGeer, P. L., & McGeer, E. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1177-7 · Cited by 467
Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models
Spangenberg, E. E., & Green, K. N. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.003 · Cited by 352
Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
Hong, H., Kim, B. S., & Im, H.-I. (2016) · International Neurourology Journal · doi:10.5213/inj.1632604.302 · Cited by 258
NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
Yin, J., Zhao, F., Chojnacki, J. E., Fulp, J., Klein, W. L., Zhang, S., & Zhu, X. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0467-9 · Cited by 232
Cui, L., Feng, L., Zhang, Z. H., & Jia, X. B. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.09.005 · Cited by 213
Li, S., Sun, X., Xu, L., Sun, R., Ma, Z., Deng, X., Liu, B., Fu, Q., Qu, R., & Ma, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.07.041 · Cited by 124
Liu, M., Chen, F., Sha, L., Wang, S., Lin, T., Yao, L., He, M., Yao, Z., Liu, H., Zhu, Z., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8608-2 · Cited by 117
Self-citationExaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat
Gordon, M. N., Schreier, W. A., Ou, X., Holcomb, L. A., & Morgan, D. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971110)388:1<106::aid-cne7>3.0.co;2-5 · Cited by 111
Apoptosis and in vitro Alzheimer’s disease neuronal models
Calissano, P., Matrone, C., & Amadoro, G. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.7704 · Cited by 111
Alzheimer’s Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs
McGeer, P. L., Guo, J. P., Lee, M., Kennedy, K., & McGeer, E. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170706 · Cited by 79
Chen, C., Li, X., Gao, P., Tu, Y., Zhao, M.-L., Li, J., Zhang, S., & Liang, H. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9601-9 · Cited by 75
Liu, X., & Liu, C. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.04.019 · Cited by 75
Haitao, D., Wang, H., Zhao, Y., Sun, D., & Xu, Z. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0156-z · Cited by 73
Yin, F., Liu, J., Ji, X., Wang, Y., Zidichouski, J. A., & Zhang, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.055 · Cited by 72
Inflammation and oxidative damage in Alzheimer s disease friend or foe
Galimberti, D. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s149 · Cited by 70
Urrutia, P. J., Hirsch, É. C., González-Billault, C. E., & Núñez, M. T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14005 · Cited by 69
Kumar, H., More, S. V., Han, S.-D., Choi, J.-Y., & Choi, D. (2012) · Molecules · doi:10.3390/molecules170910503 · Cited by 66
Selkoe, D. J. (1989) · Annals of Medicine · doi:10.3109/07853898909149187 · Cited by 66
Cao, G., Zhu, J., Zhong, Q., Shi, C.-F., Dang, Y., Han, W., Liu, X., Xu, M., & Chen, T. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.020 · Cited by 62
Rui, Y., & Zheng, J. Q. (2016) · Molecular Brain · doi:10.1186/s13041-016-0261-z · Cited by 62
Zhuang, P., Cui, G., Zhang, Y., Zhang, M., Guo, H. W., Zhang, J., Lu, Z., Isaiah, A. O., & Lin, Y. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12050 · Cited by 61
Shi, X., Fu, Y., Zhang, S., Ding, H., & Jin, C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1401790 · Cited by 58
Liu, M., Wang, S. R., Yao, W., Zhang, Z. J., Zhong, X., Sha, L., He, M., ZHENG, Z., & Wei, M. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.011 · Cited by 55
Self-citationHou, J., Wang, J., Zhang, P., Li, D., Zhang, C., Zhao, H., Fu, J.-H., Wang, B., & Liu, J. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.10.013 · Cited by 54
Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice
Bitto, A., Giuliani, D., Pallio, G., Irrera, N., Vandini, E., Canalini, F., Zaffe, D., Ottani, A., Minutoli, L., Rinaldi, M., et al. (2017) · Inflammation Research · doi:10.1007/s00011-017-1022-x · Cited by 53
Xiong, J., Wang, C., Chen, H., Hu, Y., Tian, L., Pan, J., & Geng, M. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.865027 · Cited by 50
Lee, B., Sur, B., Shim, I., Lee, H., & Hahm, D. (2013) · Journal of Natural Medicines · doi:10.1007/s11418-013-0782-z · Cited by 42
C-glycosyl flavonoid orientin improves chemically induced inflammatory bowel disease in mice
Sun, A., Ren, G., Deng, C., Zhang, J., Luo, X., Wu, X., Mani, S., Dou, W., & Wang, Z. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2015.12.029 · Cited by 38
Qi, Y. A., Ji, X., Chi, T., Liu, P., Jin, G., Xu, Q., Jiao, Q., Wang, L.-H., & Zou, L. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.045 · Cited by 30
Yu, H., Li, X.-Y., Zhou, X. J., Yuan, L., Ma, W., Xi, Y., Zhao, X., Wu, J., & Xiao, R. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0063-z · Cited by 25
Ding, S., Zhuge, W., Hu, J., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4833-8 · Cited by 23
Jiao, C., Gao, F., Li, O., Yu, J., Li, M., Wei, P., & Feng, M. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001032 · Cited by 18
Cited by
Zhang, J., Zheng, Y., Luo, Y., Du, Y., Zhang, X., & Fu, J. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.09.020 · Cited by 464
Liao, H., Ye, J., Gao, L., & Liu, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110917 · Cited by 333
Paudel, Y. N., Angelopoulou, E., Piperi, C., Othman, I., Aamir, K., & Shaikh, M. F. (2020) · Cells · doi:10.3390/cells9020383 · Cited by 257
The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
Azam, S., Haque, M. E., Balakrishnan, R., Kim, I.-S., & Choi, D.-K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.683459 · Cited by 255
Ding, H., Li, Y., Chen, S., Wen, Y., Zhang, S., Luo, E., Li, X., Zhong, W., & Zeng, H. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13765 · Cited by 126
Metadata
- Authors
- Jin, X., Liu, M., Zhang, D., Zhong, X., Du, K., Qian, P., Yao, W., Gao, H., & Wei, M.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2019-01-24
- Volume
- 25
- Issue
- 5
- Pages
- 575-590
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W2913751428
- Cited by
- 383
- References
- 47
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.